Paladin Labs is a part of Endo International plc — a global specialty pharmaceutical company, improving lives, creating value.   Learn More

A leader in specialty pharmaceutical innovation

Welcome to Paladin Labs
With headquarters in Montréal, Canada, Paladin Labs Inc. is a leading specialty pharmaceutical company focused on acquiring or licensing emerging pharmaceuticals for the Canadian market.

Their dedicated sales and marketing organization has propelled Paladin to become one of Canada’s pioneers in specialty pharmaceuticals.

Paladin is an operating company of Endo International plc (NASDAQ: ENDP) (TSX: ENL), a global specialty pharmaceutical company focused on improving patients’ lives while creating shareholder value.

Investor Information

Endo International plc

ENDP (Common Stock) NASDAQ
Price $61.00
Change and Percent Change +0.72 (+1.19%)

An innovative specialty pharmaceutical company